Gynecomastia News and Research

RSS

Gynecomastia is a condition where men develop abnormally large breasts. The enlargement is not of fat but breast tissues.

Cyclical breast pain: Common causes and when to get a mammogram

If you've ever felt pain, tenderness and tightness – maybe even a sharp, stabbing sensation – in your breasts, it's hard not to jump to conclusions.

25 Jan 2023

Smoking marijuana damages the lungs more than tobacco

Lungs of marijuana smokers exhibit greater levels of airway inflammatory markers and emphysema as compared to those of tobacco-only smokers.

15 Nov 2022

Emphysema rates higher among marijuana smokers than cigarette smokers

Airway inflammation and emphysema are more common in marijuana smokers than cigarette smokers, according to a study published in Radiology, a journal of the Radiological Society of North America.

15 Nov 2022

Cedars Sinai experts remind men of their breast cancer risk

Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.

21 Oct 2022

Intense and targeted radiotherapy could slow progression of certain prostate cancers

Targeted and strong doses of stereotactic ablative radiation (SABR) radiotherapy could slow progression in prostate cancer.

26 Mar 2020

Lavender oil exposure linked to abnormal breast growth in young girls

Abnormal breast growth in young girls is linked to lavender oil exposure, according to a recent study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

14 Aug 2019

New report reveals a 29% increase in plastic surgery among men since 2000

Just as women can turn to a suite of procedures, known as the "Mommy Makeover," more men are embracing their own set of treatments, the "Daddy Do-Over," to boost their confidence and improve their physical appearance.

12 Jun 2019

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

30 Aug 2018

Hormone lab tests not necessary for most teens with gynecomastia

Routine assessment by an endocrinologist and laboratory tests to measure hormone levels aren't necessary in most adolescent boys with gynecomastia, concludes a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

30 Jun 2018

Study links essential oils to hormonal imbalances

A new study has found that common chemicals found in essential oils may have adverse health impacts, contrary to popular belief.

27 Mar 2018

Essential oils linked to abnormal breast development in boys

A new study has found that essential oils such as lavender and tea tree oils are connected to development of abnormal breast development in young boys. They researchers found eight different chemicals present in these oils that can interfere with hormonal development in boys. The study results are to be presented today (19th of March 2018) at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago.

19 Mar 2018

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.

18 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Gynecomastia affects mental, emotional health in adolescent males, study finds

Persistent breast enlargement (gynecomastia) negatively affects self-esteem and other areas of mental and emotional health in adolescent males, reports the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

3 Apr 2013

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).

31 Oct 2012

Male cyclists may experience hormonal imbalances that affect reproductive health

A new study conducted by UCLA School of Nursing researchers has found that serious leisure male cyclists may experience hormonal imbalances that could affect their reproductive health. The study, "Reproductive Hormones and Interleukin-6 in Serious Leisure Male Athletes," was published in the European Journal of Applied Physiology.

21 May 2012

JS Genetics announces availability of XCAT-KS buccal swab test

JS Genetics announces the availability of XCAT-KS, its proprietary buccal swab test for the diagnosis of Klinefelter syndrome (KS) and other male sex chromosome aneuploidies.

3 May 2012

BPH, hair loss prevention drugs may produce adverse side effects in men

Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.

12 Jan 2011

Growth hormone boosts sprinting capacity in athletes but may have serious side effects

Human Growth Hormone (hGH) has long been used among athletes and body builders for stronger and a more muscular bodies over the past four decades. However it is only now that Sydney-based researchers have published a study that shows that hGH offers no such benefits.

3 May 2010

AstraZeneca receives six months pediatric exclusivity patent extension for ARIMIDEX (anastrozole)

AstraZeneca has announced that the United States (US) Food and Drug Administration (FDA) has granted an additional six-month period of exclusivity to market ARIMIDEX (anastrozole) for its licensed breast cancer indications until June 2010.

2 Dec 2007